Searched for
GSK PFIZER
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- GSK set to get $500 million from settlement of mRNA lawsuitCureVac NV has settled its US patent dispute with Pfizer and BioNTech SE regarding mRNA vaccines, resulting in GSK receiving up to $500 mil...
- Pfizer to cut stake in Sensodyne-maker Haleon to 7.3%, says bookrunnerPfizer is selling around 700 million ordinary shares in Haleon, reducing its stake from 15% to about 7.3%. This sale follows its earlier re...
- GSK raises $1.5 billion from sale of remaining Haleon stakeBritish drugmaker GSK has raised 1.25 billion pounds ($1.52 billion) from a sale of its remaining stake in consumer healthcare company Hale...
- Pfizer Q1 Results: Co lifts profit view on cost cuts, smaller drop in PaxlovidPfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates, boosted by cost cu...
- GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technologyGlaxoSmithKline (GSK) has filed a lawsuit against Pfizer and BioNTech in Delaware federal court, alleging infringement of GSK's patents rel...
- Pfizer to exit GSK's consumer health arm Haleon after spin-offBefore the spinoff, the holding company for the consumer health business will pay dividends to GSK and Pfizer. That will translate to GSK r...
- Unilever will not raise rejected 50 bn pound bid for GSK consumer armGSK has rejected three bids from Unilever for its consumer arm, which is home to brands such as Sensodyne toothpaste, Emergen-C vitamin sup...
- Unilever still eyes GSK-Pfizer unit after £50 bn bid rebuffedGSK said on Saturday that it had received three unsolicited offers from Unilever for GSK Consumer Healthcare, but they were all rejected as...
- India may have to wait longer for Pfizer, GSK's Covid drugsLast month Pfizer had announced an agreement with the UN's Medicines Patent Pool (MPP) for licensing antiviral intellectual property to MPP...
- GSK sees lower profit this year, split plans on trackThe world's biggest vaccine maker by sales said on Wednesday it expected adjusted earnings to fall by a mid- to high-single digit percentag...
- CCI approves GSK, Pfizer joint venture in consumer healthcareGSK had in December last year announced that it had reached an agreement with Pfizer to combine the two companies’ consumer healthcare busi...
- CCI approves GSK, Pfizer consumer healthcare JV formationAfter the deal, GSK will have a majority controlling equity interest of 68 per cent in the combined consumer healthcare business.
- GSK-Pfizer combo likely to be booster dose for brands in IndiaGSK and Pfizer said on Wednesday they will merge their consumer healthcare businesses, which have combined sales of $12 billion, by creatin...
- Pfizer and GlaxoSmithKline initiate leadership reshuffle in face of competition from domestic playersTop multinational drug makers Pfizer and GlaxoSmithKline have initiated major reshuffle of senior leadership teams in India in face of comp...
- Pick-up in local market boosts pharma MNCsA pick-up in the local pharma market augurs well for MNCs which are still recovering from the adverse impact of drug price control on high-...
- More drug MNCs join the stake-hike bandwagonAfter the two leading pharma multinationals recently increased their stakes in their Indian units, people connected with the industry say t...
- Pfizer offer for Ranbaxy is 'market speculation'A possible counter offer by US giant Pfizer to buy 65% non-promoter stake in Ranbaxy is just a “market speculation”, a source close to the ...
- GSK to offer $15 bn for Pfizer unit: reportThe British-based pharmaceutical group GlaxoSmithKline (GSK) is planning to offer more than $15 billion dollars for the consumer health car...
Load More
